IMBdx Inc

XKRX:461030 (Korea (the Republic of))  
â‚© 17150.00 (-6.08%) Sep 27
At Loss
P/B:
6.38
Market Cap:
â‚© 240.40B ($ 183.47M)
Enterprise V:
â‚© 205.25B ($ 156.65M)
Volume:
445.10K
Avg Vol (2M):
2.35M
Trade In:
Volume:
445.10K
At Loss

Business Description

Compare
Compare
Traded in other countries / regions
461030.Korea
IPO Date
2024-04-03
Description
IMBdx Inc detects and analyzes the genomic profile of tumor DNA with a single draw of blood. It provides personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Its AlphaLiquid platform offers ctDNA-based precision diagnostics solutions across the full continuum of cancer care, from therapy selection (AlphaLiquid 100/HRR) to recurrence and minimal residual disease(MRD) monitoring (CancerDetect), and multi-cancer early detection (CancerFind). Its services are Clinical Service BioPharma, Research, and Healthcare Checkup.
Name Current Vs Industry Vs History
Cash-To-Debt 137.84
Equity-to-Asset 0.92
Debt-to-Equity 0.01
Debt-to-EBITDA -0.05
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 32.55
9-Day RSI 40.38
14-Day RSI 44.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.77
Quick Ratio 12.64
Cash Ratio 11.96
Days Inventory 138.73
Days Sales Outstanding 207.7
Days Payable 103.79

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 42.36
Operating Margin % -291.76
Net Margin % -290.36
FCF Margin % -118.8
ROE % -30.83
ROA % -27.94
ROIC % -130.15
ROC (Joel Greenblatt) % -151.37
ROCE % -30.27
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

IMBdx Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil â‚©) 2,002.019
EPS (TTM) (â‚©) -446
Beta 0
Volatility % 0
14-Day RSI 44.8
14-Day ATR (â‚©) 1788.057461
20-Day SMA (â‚©) 18870
12-1 Month Momentum % 0
52-Week Range (â‚©) 8430 - 40550
Shares Outstanding (Mil) 14.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

IMBdx Inc Filings

Filing Date Document Date Form
No Filing Data

IMBdx Inc Stock Events

Financials Calendars
Event Date Price(â‚©)
No Event Data

IMBdx Inc Frequently Asked Questions

What is IMBdx Inc(XKRX:461030)'s stock price today?
The current price of XKRX:461030 is â‚©17150.00. The 52 week high of XKRX:461030 is â‚©40550.00 and 52 week low is â‚©8430.00.
When is next earnings date of IMBdx Inc(XKRX:461030)?
The next earnings date of IMBdx Inc(XKRX:461030) is .
Does IMBdx Inc(XKRX:461030) pay dividends? If so, how much?
IMBdx Inc(XKRX:461030) does not pay dividend.

Press Release

Subject Date
No Press Release